Clinical trial
Metabolomic Phenotyping After Surgery for Colon Cancer: Study of Novel Predictive Biomarkers
NCT02789709 is registered in ClinicalTrials.gov with Parc de Salut Mar as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Metabolomic Phenotyping After Surgery for Colon Cancer: Study of Novel Predictive Biomarkers
- Lead sponsor
- Parc de Salut Mar
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 31, 2016
- Completion date
- December 31, 2019
- Enrollment
- 130 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
colon cancer